Brookes M J, Hughes S, Turner F E, Reynolds G, Sharma N, Ismail T, Berx G, McKie A T, Hotchin N, Anderson G J, Iqbal T, Tselepis C
Cancer Research UK Institute for Cancer Studies, University of Birmingham, Vincent Drive, Birmingham B15 2TH, UK.
Gut. 2006 Oct;55(10):1449-60. doi: 10.1136/gut.2006.094060. Epub 2006 Apr 26.
Total body iron and high dietary iron intake are risk factors for colorectal cancer. To date there is no comprehensive characterisation of iron transport proteins in progression to colorectal carcinoma. In this study, we examined expression of iron import (duodenal cytochrome b (DCYTB), divalent metal transporter 1 (DMT1), and transferrin receptor 1 (TfR1)) and export (hephaestin (HEPH) and ferroportin (FPN)) proteins in colorectal carcinoma.
Perl's staining was used to examine colonocyte iron content. Real time polymerase chain reaction (PCR) and western blotting were used to examine mRNA and protein levels of the molecules of interest in 11 human colorectal cancers. Semiquantitative immunohistochemistry was used to verify protein levels and information on cellular localisation. The effect of iron loading on E-cadherin expression in SW480 and Caco-2 cell lines was examined by promoter assays, real time PCR and western blotting.
Perl's staining showed increased iron in colorectal cancers, and there was a corresponding overexpression of components of the intracellular iron import machinery (DCYTB, DMT1, and TfR1). The iron exporter FPN was also overexpressed, but its intracellular location, combined with reduced HEPH levels, suggests reduced iron efflux in the majority of colorectal cancers examined. Loss of HEPH and FPN expression was associated with more advanced disease. Iron loading Caco-2 and SW480 cells caused cellular proliferation and E-cadherin repression.
Progression to colorectal cancer is associated with increased expression in iron import proteins and a block in iron export due to decreased expression and aberrant localisation of HEPH and FPN, respectively. This results in increased intracellular iron which may induce proliferation and repress cell adhesion.
机体总铁量及高膳食铁摄入量是结直肠癌的危险因素。迄今为止,尚无关于结直肠癌进展过程中铁转运蛋白的全面特征描述。在本研究中,我们检测了结直肠癌中铁摄取蛋白(十二指肠细胞色素b(DCYTB)、二价金属转运体1(DMT1)和转铁蛋白受体1(TfR1))及铁输出蛋白(亚铁氧化酶(HEPH)和铁转运蛋白(FPN))的表达情况。
采用Perl染色检测结肠细胞铁含量。运用实时聚合酶链反应(PCR)和蛋白质印迹法检测11例人类结直肠癌中相关分子的mRNA和蛋白水平。采用半定量免疫组织化学法验证蛋白水平及细胞定位信息。通过启动子分析、实时PCR和蛋白质印迹法检测铁负荷对SW480和Caco - 2细胞系中E - 钙黏蛋白表达的影响。
Perl染色显示结直肠癌中铁含量增加,细胞内铁摄取机制相关成分(DCYTB、DMT1和TfR1)相应过度表达。铁输出蛋白FPN也过度表达,但其细胞内定位以及HEPH水平降低表明,在大多数检测的结直肠癌中铁外流减少。HEPH和FPN表达缺失与疾病进展程度更高相关。铁负荷处理Caco - 2和SW480细胞导致细胞增殖及E - 钙黏蛋白表达受抑制。
结直肠癌进展与铁摄取蛋白表达增加以及铁输出受阻有关,铁输出受阻分别是由于HEPH和FPN表达降低及定位异常所致。这导致细胞内铁含量增加,可能诱导细胞增殖并抑制细胞黏附。